Related by context. All words. (Click for frequent words.) 65 Emphasizes Importance 63 Re Affirms 62 Urgent Need 62 Announcement Regarding 62 Step Toward 61 Cites Progress 61 Report Suggests 61 Underscores Importance 60 Long Term Commitment 60 Reaffirms Commitment 60 Success Depends 60 Poll Shows Support 60 Move Toward 60 Experts Urge 60 Highlights Importance 60 Expresses Confidence 60 Validates 60 Refines 60 Critical Juncture 60 Significant Increase 59 Cast Doubt 59 First Step Toward 59 Remains Committed 59 Furthers 59 Leadership Position 59 Remains Elusive 59 Affirms Commitment 59 Puts Focus 59 Biggest Threat 59 Raises Doubts About 59 Outlines Vision 59 Key Milestones 59 Differences Between 59 Challenges Remain 59 Distinguishes 59 Hails Passage 58 Pressure Builds 58 Focus Shifts 58 Viable Alternative 58 Reaffirm Commitment 58 Cautious Optimism 58 Persists 58 Relationship Between 58 Underscores Need 58 Emphasizes Need 58 Report Identifies 58 Reaffirms Support 58 Actions Needed 58 Renews Call 58 Stresses Need 58 Could Undermine 58 Play Crucial Role 58 Lags Behind 58 Steps Toward 58 Legislation Introduced 58 Critical Role 58 Important Milestone 58 Could Backfire 58 Recommends Changes 58 Sees Possible 58 Revised Upward 58 Stresses Importance 58 Draws Mixed Reaction 58 Moves Towards 58 Powerful Tool 58 Outlines Strategy 58 Issues Surrounding 58 Report Examines 58 Lay Groundwork 58 Stepped Up 58 Draw Attention 58 Remain Committed 58 Strongly Supports 57 Undercuts 57 Draws Mixed Reactions 57 Reasserts 57 Raises Concerns Over 57 Reshapes 57 Missed Opportunity 57 Bodes Well 57 Study Indicates 57 Phasing Out 57 Outlines Steps 57 Clears Path 57 Remains Unchanged 57 Expert Discusses 57 Spells Out 57 Ramping Up 57 Gaining Traction 57 Examines Impact 57 Multi Billion Dollar 57 Urges Stronger 57 Poses Challenges 57 Submits Application 57 Lobbying Efforts 57 Lawmaker Calls 57 Step Towards 57 Applauds Passage 57 Fourth Consecutive 57 Expresses Concern About 57 Lays Out 57 Provides Guidance 57 Achieves Significant 57 Admits Mistakes 57 Raises Questions About 57 Faces Challenges 57 Biotech Crops 57 Seeks Compromise 57 Poses Challenge 57 Raises Doubts 57 Receives Recognition 57 Reiterates Commitment 57 Groups Urge 57 Signals Shift 57 Gaining Steam 57 Milestone Reached 57 Renews Commitment 57 Retools 57 Be Studied 57 Casts Doubts 57 Expresses Hope 57 Stress Importance 57 Paves Way 57 Further Validates 57 Must Adapt 57 Epilepsy Drug 57 Report Indicates 57 Fourth Consecutive Year 57 Sixth Consecutive 57 Significantly Reduce 57 Shifts Toward 57 Reinforces Commitment 57 Must Cooperate 57 Pave Way 57 Must Rethink 57 Outlines Goals 57 Report Cites 57 Awarded Prestigious 56 Proposed Rule Changes 56 Results Confirm 56 StockSource.us Reports 56 Reverses Course 56 Urgently Needed 56 Double Edged Sword 56 Could Harm 56 Provides Updates 56 Could Endanger 56 Wins Approval 56 Report Sheds Light 56 Sets Goal 56 Hopeful Signs 56 Must Accept 56 Expert Says 56 Remains Confident 56 Panel Finds 56 Takes Steps 56 Will Backfire 56 Shows Promise 56 Ongoing Commitment 56 Bigger Role 56 Eluded 56 Sets Ambitious 56 Passes Resolution 56 Create Jobs 56 Sees Progress 56 Questions Arise 56 Questions Remain About 56 Foreshadows 56 Senators Urge 56 Improve Quality 56 Sees Positive 56 Disconnect Between 56 Backpedals 56 Receives Patent 56 Gaining Momentum 56 Correlation Between 56 Raises Concerns About 56 Announce Collaboration 56 Hits Roadblock 56 Grave Threat 56 Contracts Awarded 56 Highlight Importance 56 Summarizes 56 Justifies 56 Proposed Changes 56 Lowest Ever 56 TriCo Bancshares Announces 56 Renews Calls 56 Trend Toward 56 Unlock Secrets 56 Takes Step Toward 56 Reaffirms 56 Envoy Calls 56 Lie Ahead 56 Expand Collaboration 56 Achieves Milestone 56 Experts Weigh 56 Effort Needed 56 Voices Concern 56 Sign Pact 56 Renews Debate 56 Report Reveals 56 Underscore Need 56 Lowest Level 56 Holds Firm 56 Annan Urges 56 Proactive Approach 56 House Panel Approves 56 Long Overdue 56 Contradicts 56 Fifth Consecutive 56 Makes Strides 56 Interrogation Tactics 56 Cut Emissions 56 Panel Examines 56 Still Exist 56 Dramatic Increase 55 Cervical Cancer Vaccine 55 Study Identifies 55 Seventh Consecutive Year 55 Faces Obstacles 55 Vastly Different 55 Study Underscores 55 Dashes Hopes 55 Demonstrates Commitment 55 Path Toward 55 Raises Concerns 55 Highest Priority 55 Viable Option 55 Accomplishes 55 Accelerate Adoption 55 Be Discussed 55 Cites Positive 55 Troop Cuts 55 Gain Traction 55 Collaborative Approach 55 Resists Calls 55 Nears Decision 55 Could Derail 55 Momentum Builds 55 Shoring Up 55 Productivity Gains 55 Continues Commitment 55 Experts Advise 55 Too Costly 55 Cites Need 55 Study Sheds Light 55 Cautiously Optimistic About 55 Envoy Urges 55 Raises Hopes 55 Restates 55 Provides Detailed 55 Statement Regarding 55 Remains Hopeful 55 Considers Options 55 Pressure Mounts 55 Undermines 55 Compelling Case 55 Announces Publication 55 Well Positioned 55 Worsens 55 Expert Predicts 55 Help Improve 55 Focuses Attention 55 Partisan Divide 55 Renewed Commitment 55 Draws Attention 55 Antibiotic Use 55 Showing Signs 55 Long Awaited 55 Regains Full 55 What Constitutes 55 Portend 55 Seek Compromise 55 Clock Ticking 55 Drops Sharply 55 Survey Uncovers 55 Underscores 55 Challenges Ahead 55 Racial Disparities 55 Remain Unchanged 55 Receives Conditional Approval 55 Draws Fire 55 Multibillion Dollar 55 Gender Differences 55 Disagrees With 55 Cautiously Optimistic 55 Retracts 55 Expands Commitment 55 Key Role 55 Jeopardizes 55 Misses Deadline 55 Sustained Growth 55 Aethlon Medical Releases 55 Touts Benefits 55 Publicizes 55 Final Stages 55 Outlines 55 Op Ed Contributor 55 Must Confront 55 Stands Behind 55 Judge Overturns 55 Mideast Cease Fire 55 Growing Importance 55 Raises Concern 55 Report Outlines 55 Stimulate Economy 55 Desperately Needs 55 Significantly Improve 55 Overestimated 55 Host Webinar 55 Senate Panel Approves 55 Sees Continued 55 Sets Timetable 55 Patents Issued 55 Prospects Dim 55 Updates Shareholders 55 Spark Debate 55 Exemplifies 55 Faces Hurdles 55 Clears Hurdle 55 Provides Unprecedented 55 Attains 55 Expresses Disappointment 55 Renounces 55 Deteriorates 55 Aide Says 55 Bishops Urge 55 Gains Ground 55 Urges Patience 55 Report Analyzes 55 Coalition Applauds 55 Overstates 55 Remains Strong 55 Temporarily Suspends 55 Avian Flu Vaccine 55 Strives 55 Makes Headway 55 Ctd 55 Significantly Improved 55 Sows Seeds 55 Receives Highest 55 Groups Seek 55 Tough Decisions 55 Would Weaken 55 Environmental Impacts 55 Shed Light 55 Study Examines 55 Move Towards 55 Action Lawsuit 55 Squabble Over 55 Modest Gains 55 Shows Signs 55 Patient Enrollment 55 Submits Proposal 55 Could Hamper 55 Still Lags 55 Poll Indicates 55 Argues Against 55 Outlines Strategies 55 Could Hinder 55 Less Than Half 55 Seeks Wider 55 Break Deadlock 55 Obtains Financing 55 Pursues 55 Lawmakers Seek 55 Panel Advises 55 Must Improve 55 Committment 55 Rate Climbs 55 Continues Aggressive 55 Official Defends 54 Prepared Remarks 54 Helps Improve 54 Plays Role 54 Has Decided 54 Steep Rise 54 Growth Spurt 54 Renew Commitment 54 Held Accountable 54 Study Confirms 54 Pros Cons 54 Deficit Cuts 54 Considers Easing 54 Agreement Reached 54 News Unternehmensnachrichten 54 NewsMax.com Wires 54 Closely Linked 54 Latest Developments 54 Refocuses 54 Op Ed Columnist 54 Causes Concern 54 Troop Buildup 54 Outlines Plan 54 Cautions Against 54 Expand Relationship 54 Strengthens Balance Sheet 54 Reduce Deficit 54 Bestows 54 Looks Toward 54 Remains Steady 54 Sharply Criticizes 54 Faces Uphill Battle 54 Significantly Expand 54 Realigns 54 Is Unconstitutional 54 Move Closer 54 Leaders Agree 54 Announces Intention 54 Granted Orphan Drug 54 Immigration Overhaul 54 Suggests Ways 54 Shifts Focus 54 Webinar Focuses 54 Root Causes 54 Outlines Plans 54 Leaders Urge 54 Sets Example 54 Debate Rages 54 Study Uncovers 54 Smooth Transition 54 Perpetuates 54 Concerns Remain 54 Reiterates Support 54 Overshadow 54 Pledges Support 54 Introduces Legislation 54 Edges Toward 54 Casts Doubt 54 Official Warns 54 Holds Steady 54 Issues Statement Regarding 54 Percent Jump 54 Faster Than Expected 54 Helps Ensure 54 Gain Momentum 54 Leading Provider 54 Univest Corporation Declares 54 Makes Significant 54 Reaches Milestone 54 Could Trigger 54 Argument Against 54 Treating Depression 54 Troop Withdrawals 54 Activists Urge 54 Envoy Says 54 Reinforces 54 Announce Joint Venture 54 Looks Ahead 54 Receives Prestigious Award 54 Receives Orphan Drug 54 Jeopardize 54 Senators Propose 54 Remains Unclear 54 Energizes 54 Provides Comprehensive 54 Migraine Drug 54 Negotiators Agree 54 Hits Speed Bump 54 Potential Impacts 54 Sixth Consecutive Year 54 Sees Significant 54 Talks Underway 54 Lawsuit Challenging 54 Confirms Commitment 54 Opportunities Exist 54 Funding Shortfall 54 Record Levels 54 Up Sharply 54 Portends 54 Poses Risks 54 Hematological Cancers 54 Classifies 54 Continues Unabated 54 Gives Boost 54 Pessimistic About 54 Being Studied 54 Substantial Increase 54 Receive Prestigious 54 Growing Problem 54 Could Weaken 54 Foresees 54 Offing 54 Lawmakers Urge 54 Pushes Back 54 Leaders Gather 54 Regulatory Overhaul 54 Expanded Role 54 Receives Commitment 54 Symposium Focuses 54 Challenges Facing 54 Urges Caution 54 Immunomedics Announces 54 Presses Ahead 54 Improve Profitability 54 Growing Rapidly 54 Slight Gains 54 Launches Breakthrough 54 Take Step Toward 54 Be Evaluated 54 Stands Firm 54 Diagnostic Tests 54 Issues Statement 54 Differs 54 Leans Toward 54 Privacy Breaches 54 Tougher Stance 54 Seeks Stronger 54 Expresses Concern Over 54 Pending Acquisition 54 Sweeping Changes 54 Sees Opportunity 54 Defend Itself 54 Remain Positive 54 Results Reflect 54 Bipartisan Support 54 Envoy Sees 54 Reconfirms 54 Outline Plans 54 Puts Pressure 54 Sharpens Focus 54 Issues Guidance 54 Strengthen Ties 54 Serious Problem 54 Faces Criticism 54 Moves Closer 54 Becomes Easier 54 Alarming Rise 54 Receives Notification 54 Backs Away 54 Troop Deployment 54 Greatest Threat 54 Maintains Strong 54 Outstrip 54 Breaks Ranks 54 Book Explores 54 Significant Improvements 54 Kaydon Corporation Announces 54 Reduce Greenhouse Gas 54 Renews Pledge 54 Provides Clarification 54 Lays Out Plan 54 Identifies Key 54 Prolongs 54 Researchers Uncover 54 Reduce Carbon Emissions 54 Devastating Impact 54 Panel Discusses 54 Pared Down 54 Gives Thumbs Up 54 Official Criticizes 54 Seeks Delay 54 Bailout Funds 54 Announces Presentation 54 Evolves 54 Settle Suit Over 54 Lupus Drug 54 Addresses Critical 54 Remain Divided 54 Proves Effective 54 Third Consecutive Year 54 Congratulates 54 Poses Risk 54 Leaning Toward 54 Often Overlooked 54 Disavows 54 Moves Toward 54 Prompts Calls 54 Better Manage 54 Religious Persecution 54 Can Be Avoided 54 Troop Withdrawal 54 Cut Greenhouse Gases 54 Misrepresents 54 Study Analyzes 54 Adviser Resigns 54 Provides Glimpse 54 Secures Financing 54 Omits 54 Expresses Optimism 54 Practical Advice 54 Cultivates 54 Accelerates 54 Pivotal Role 54 Pre Emptive 54 Receives Milestone Payment 54 Announce Signing 54 Discourages 54 Diminishes 54 Differs From 54 Marks Milestone 54 Shows Modest 54 Earns Prestigious 54 Civilian Casualties 54 Lowers Expectations 54 Grants Awarded 54 Takes Backseat 54 Bipartisan Effort 54 Must Embrace 54 Raises Possibility 54 Announces Discontinuation 54 Expresses Support 54 Peaceful Resolution 54 Stresses Importance Of 54 Seeks Approval 54 Curtails 54 Critical Thinking Skills 54 Groups Decry 54 Mixed Reaction 54 Sixth Consecutive Quarter 54 Patented Technology 54 Reinforces Need 54 Weigh Options 54 Mixed Reviews 54 Dramatically Improves 54 Malpractice Suits 54 Urgently Needs 54 Market Awaits 54 Lifts Restrictions 54 Emissions Cuts 53 Partisan Politics 53 Ayoon wa Azan 53 Paying Off 53 Make Inroads 53 Debate Rages Over 53 Systemic Failure 53 Raise Doubts 53 Momentum Continues 53 Lawsuit Seeks 53 Helps Identify 53 Remains Uncertain 53 Investors Await 53 Sends Mixed Signals 53 Counteroffer 53 Biggest Obstacle 53 Paints Bleak Picture 53 Reassures 53 Amasses 53 Malaria Vaccine 53 Must Defend 53 Tough Task 53 Mixed Reactions 53 Endangers 53 Significant Reduction 53 Study Reinforces 53 Compromise Reached 53 Approach Needed 53 Lose Ground 53 Loses Ground 53 Lawmakers Oppose 53 Bigger Problem 53 Hold Hearings 53 Genes Linked 53 Expands Scope 53 Helps Organizations 53 Signs Option Agreement 53 Report Criticizes 53 Markets Examine 53 Draws Criticism 53 Sizing Up 53 Feds Approve 53 Formalizes 53 Study Casts Doubt 53 Largely Unchanged 53 Upcoming Milestones 53 Margin Expansion 53 Washn 53 Grapples With 53 Draws Praise 53 Task Force Recommends 53 Showdown Looms 53 Has Achieved 53 Significantly Increases 53 Gets Mixed Reviews 53 Be Examined 53 Cost Efficiencies 53 Seeps Into 53 Be Explored 53 Complicates 53 See Consortiumnews.com s 53 Deadline Approaches 53 Broadens Its 53 Motives Behind 53 Meth Addiction 53 Receives Endorsement 53 Cut Deficit 53 Widely Available 53 Tax Rebates 53 Has Received 53 Overwhelmingly Approve 53 Talks Collapse 53 Study Proves 53 Rises Sharply 53 Denies Claims 53 Contradict 53 Panel Debates 53 Scoffs At 53 Denounces 53 Stock Repurchases 53 Short Lived 53 Brain Cells 53 Scaling Back 53 Could Disappear 53 Softens Tone 53 Geopolitical Diary 53 Scaled Back 53 Nutrition Labels 53 Recession Worries 53 Pushes Ahead 53 Outlines Agenda 53 Move Quickly 53 Challenges Loom 53 Extend Deadline 53 Lowers Outlook 53 Lends Support 53 Passes Milestone 53 Scrutinizes 53 Deficit Cutting 53 Initiates Clinical Trial 53 Acknowledges 53 Gender Inequality 53 Could Prove 53 Rights Abuses 53 Dire Consequences 53 Purchasing Decisions 53 Draw Criticism 53 Poses Threat 53 Awaits Approval 53 Economists Predict 53 Overwhelming Support 53 Announces Intent 53 Underpin 53 Could Complicate 53 Stance Against 53 Losing Steam 53 Downward Trend 53 Sounds Alarm 53 Data Suggest 53 Improve Efficiency 53 Miraculins Announces 53 Significant Improvement 53 Successful Deployment 53 Signaled 53 Hits Snag 53 Exceeds Expectations 53 Rapid Expansion 53 Adverse Outcomes 53 Ninth Consecutive 53 Step Backward 53 Vote Nears 53 Stave Off 53 Proves Successful 53 Delivers Strong 53 Develops Innovative 53 Fifth Consecutive Year 53 Expresses Concern 53 Panel Weighs 53 Organizational Structure 53 Must Prove 53 Face Hurdles 53 Recieves 53 Immune Cells 53 Introduce Legislation 53 Opinion Piece Says 53 Still Unclear 53 Taps Into 53 Questions Linger 53 Reactivates 53 Holds Promise 53 Negative Effects 53 RNAi Therapeutics 53 Debate Heats Up 53 Legally Binding 53 Reinforces Importance 53 Gains Traction 53 Third Consecutive 53 Lowers Costs 53 Antiviral Drugs 53 Recurrent Breast Cancer 53 Official Urges 53 Has Passed 53 Receives Favorable 53 Slower Growth 53 Gaps Remain 53 Must Evolve 53 Regain Control 53 Provide Comprehensive 53 Dipping Into 53 Larger Role 53 Significant Milestone 53 Sends Message 53 Overcoming Barriers 53 Clears Way 53 Renews Push 53 Ignites Debate 53 Democrats Assail 53 Stricter Rules 53 Biologic Drugs 53 Scientists Uncover 53 Restricts Access 53 Proxy Proposals 53 Innovative Approach 53 Larger Than Expected 53 Jumps Higher 53 Gets Boost From 53 Loom Large 53 Long Term 53 Pressure Grows 53 Remain Above 53 Beefs Up 53 Restrains 53 Feds Urge 53 Leaders Vow 53 Highest Level Since 53 Effort Fails 53 Novel Approach 53 Divulges 53 Condemn Attacks 53 Patents Covering 53 Leaders Endorse 53 Applauds Introduction 53 Help Manage 53 Be Removed 53 Reforms Needed 53 Attitudes Towards 53 Toughens 53 Successfully Concludes 53 Diversifies 53 Bodes Ill 53 Put Brakes 53 Less Costly 53 Difficult Task 53 Violence Worsens 53 Further Strengthens 53 Reduces Risk 53 Study Predicts 53 Help Protect 53 Adversely Affects 53 Underlies 53 Puts Emphasis 53 Could Threaten 53 Jointly Explore 53 Poniard Pharmaceuticals Announces 53 Publishes Updated 53 Cross Hairs 53 Achieve Breakthrough 53 Pays Off 53 Backlash Against 53 Proposed Legislation 53 Without Compromising 53 Host Webcast 53 Faces Dilemma 53 Deplores 53 Short Shrift 53 Than Ever 53 AIDS Epidemic 53 Raise Concern 53 Vast Majority 53 Economists React 53 Cancer Stem Cells 53 Wide Ranging 53 Shows Weakness 53 Shifts Gears 53 Earns Recognition 53 Loan Guarantees 53 Provide Valuable 53 Unique Approach 53 Gov't Seeks 53 Outlines Priorities 53 McCain Myth Buster 53 Crucial Role 53 Bill Clears Hurdle 53 Proven Effective 53 Heightens 53 Emphasizes 53 Develops Novel 53 HCV Protease Inhibitor 53 Treads Water 53 Poll Suggests 53 Advocates Urge 53 Weak Economy 53 Gives Glimpse 53 Appears Headed 53 Announce Completion 53 Disturbing Trend 53 Stem Cell Treatment 53 Stem Cell Breakthrough 53 Climate Pact 53 Transparency Accountability 53 Study Demonstrates 53 Nudges 53 Uphill Fight 53 Past Decade 53 Carried Out 53 Earmark Reform 53 Commitment 53 Delays Vote 53 Accurately Predict 53 Interest Rate Increases 53 Improving Efficiency 53 Counter Productive 53 Upcoming Webinar 53 Deal Struck 53 Deepening Crisis 53 Tool Helps 53 Edges Closer 53 Cuts Loom 53 Another Step Toward 53 Op Ed Contributors 53 Abortion Stance 53 Tops List 53 Insights Into 53 Celebrates Decade 53 Files Provisional 53 Assails 53 Data Indicate 53 Ambitious Agenda 53 Regains 52 Demonstrates Ability 52 Diagnostic Criteria 52 Reducing Greenhouse Gas 52 Violence Threatens 52 Essential Element 52 Reduce Poverty 52 Lag Behind 52 & Sullivan Recognizes 52 Important Role 52 Demonstrate Commitment 52 Blind Spots 52 Study Concludes 52 Study Assesses 52 Dramatically Reduce 52 Removing Barriers 52 Offers Incentives 52 Face Daunting 52 Renegotiates 52 Pacific Rubiales Announces 52 Help Sought 52 Accepts Responsibility 52 Inching Toward 52 Signed Into 52 Significantly Expands 52 Justices Uphold 52 Different Paths 52 Tread Carefully 52 Imperil 52 Seeks Urgent 52 Challenges Faced 52 Give Keynote Address 52 Demonstrates Long Term 52 Not Budging 52 Panel Faults 52 Withholds 52 Raise Awareness About 52 Extols 52 Provides Insights 52 Stays Strong 52 Smallpox Vaccine 52 Announces Definitive Agreements 52 Uphill Battle 52 Positive Results 52 Sets Priorities 52 Eagerly Awaiting 52 Changing Role 52 Backs Off 52 Groups Warn 52 Spur Growth 52 Fallout Continues 52 Attitude Toward 52 Lymph Nodes 52 Differing Views 52 Compliance Requirements 52 Could Revolutionize 52 Hits Milestone 52 Improves Slightly 52 Reaches Goal 52 Successful Implementation 52 Speaks Volumes 52 Be Tested 52 Sees Steady 52 Second Consecutive 52 Update# 52 Announces Stockholder Approval 52 Suicide Attacks 52 Earns Top 52 PremierWest Bancorp Announces 52 Probe Finds 52 Cause Concern 52 Highest Levels 52 Few Surprises 52 Flamel Technologies Announces 52 Spend Billions 52 Awarded Highest 52 Budget Cuts Threaten 52 CEA Applauds 52 Looks Promising 52 Envoy Warns 52 Growth Slowing